NCT05713448 Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
| NCT ID | NCT05713448 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Type 1 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2021-02-24 |
| Primary Completion | 2099-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2021-02-24 with a primary completion date of 2099-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes
Eligibility Criteria
Inclusion Criteria: * Signed informed consent * Type 1 Diabetes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05713448 clinical trial?
This trial is open to participants of all sexes, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05713448 currently recruiting?
Yes, NCT05713448 is actively recruiting participants. Contact the research team at bart.vanderschueren@uzleuven.be for enrollment information.
Where is the NCT05713448 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT05713448 clinical trial?
NCT05713448 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 100,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.